Trade Summary

4 days ago, Cho Esther, serving as Chief Legal Officer at Keros Therapeutics, Inc. (KROS), sold 4,485 shares at $10.29 per share, for a total transaction value of $46,150.65. Following this transaction, Cho Esther now holds 35,770 shares of KROS.

This sale represents a 11.14% decrease in Cho Esther's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, August 18, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, August 20, 2026 at 4:10 PM ET, 2 days after the trade was made.

Keros Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.